Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp Cuts Holdings in Humana Inc (HUM)

Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lowered its stake in Humana Inc (NYSE:HUM) by 8.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 62,500 shares of the insurance provider’s stock after selling 5,400 shares during the quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s holdings in Humana were worth $18,602,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Alps Advisors Inc. lifted its position in shares of Humana by 10.0% in the second quarter. Alps Advisors Inc. now owns 3,675 shares of the insurance provider’s stock worth $1,094,000 after purchasing an additional 334 shares in the last quarter. Columbus Hill Capital Management L.P. lifted its position in shares of Humana by 57.6% in the second quarter. Columbus Hill Capital Management L.P. now owns 150,759 shares of the insurance provider’s stock worth $44,870,000 after purchasing an additional 55,100 shares in the last quarter. Synovus Financial Corp lifted its position in shares of Humana by 231.6% in the second quarter. Synovus Financial Corp now owns 1,227 shares of the insurance provider’s stock worth $365,000 after purchasing an additional 857 shares in the last quarter. Boston Advisors LLC lifted its position in shares of Humana by 27.0% in the second quarter. Boston Advisors LLC now owns 138,043 shares of the insurance provider’s stock worth $41,086,000 after purchasing an additional 29,367 shares in the last quarter. Finally, Glenview Trust Co lifted its position in shares of Humana by 7.4% in the first quarter. Glenview Trust Co now owns 35,695 shares of the insurance provider’s stock worth $9,596,000 after purchasing an additional 2,456 shares in the last quarter. 93.00% of the stock is currently owned by institutional investors and hedge funds.

In other Humana news, insider Timothy Alan Wheatley sold 11,468 shares of the company’s stock in a transaction on Tuesday, June 19th. The shares were sold at an average price of $299.40, for a total value of $3,433,519.20. Following the transaction, the insider now directly owns 3,889 shares in the company, valued at $1,164,366.60. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Cynthia H. Zipperle sold 4,886 shares of the company’s stock in a transaction on Friday, August 3rd. The shares were sold at an average price of $321.89, for a total transaction of $1,572,754.54. The disclosure for this sale can be found here. Over the last quarter, insiders sold 51,752 shares of company stock worth $16,581,234. Corporate insiders own 0.60% of the company’s stock.

A number of analysts have recently commented on HUM shares. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a research report on Wednesday, July 4th. Citigroup restated a “buy” rating and set a $340.00 target price (up from $280.00) on shares of Humana in a report on Friday, June 1st. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $326.00 target price on the stock in a report on Monday, May 21st. Bank of America boosted their target price on shares of Humana from $338.00 to $375.00 and gave the stock a “buy” rating in a report on Thursday, August 2nd. Finally, Jefferies Financial Group boosted their target price on shares of Humana from $356.00 to $372.00 and gave the stock a “buy” rating in a report on Thursday, August 2nd. Six analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $331.11.

Shares of HUM opened at $337.93 on Friday. The firm has a market cap of $45.68 billion, a P/E ratio of 28.86, a PEG ratio of 1.65 and a beta of 0.96. Humana Inc has a 1-year low of $231.90 and a 1-year high of $338.38. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.43 and a current ratio of 1.43.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, August 1st. The insurance provider reported $3.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.79 by $0.17. Humana had a net margin of 2.48% and a return on equity of 17.43%. The firm had revenue of $14.26 billion for the quarter, compared to the consensus estimate of $14.16 billion. During the same period in the previous year, the company earned $3.49 earnings per share. analysts predict that Humana Inc will post 14.18 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 26th. Shareholders of record on Friday, September 28th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $2.00 annualized dividend and a dividend yield of 0.59%. Humana’s dividend payout ratio is currently 17.08%.

About Humana

Humana Inc is a health and well-being company focused on making it easy for people to achieve best health. Its strategy integrates care delivery, the member experience, and clinical & consumer insights to encourage engagement, behavior change, proactive clinical outreach, and wellness for the people.

Featured Article: Are Wall Street analysts’ stock ratings worth following?

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit